Erythrodermic presentation of psoriasis in a patient treated with dupilumab
Sign Up to like & getrecommendations! Published in 2018 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2018.05.014
Abstract: IL: interleukin Th: T-helper D upilumab is an interleukin (IL)-4 receptor a (IL-4Ra) antagonist that inhibits IL-4 and IL13 signaling, keymediators of T-helper (Th) 2-mediated inflammation. Whereas an immune shift toward Th2 drives atopic dermatitis… read more here.
Keywords: erythrodermic presentation; patient treated; treated dupilumab; psoriasis patient ... See more keywords